FindTrial
Sign In

Magnesium as adjuvant for adductor canal block and ipack for post operative analgesia in patients undergoing total knee arthroplasty

Effectiveness of Magnesium as an adjuvant for adductor canal block with ipack for postoperative analgesia in patients undergoing unilateral total knee arthroplasty:Prospective double blinded study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/10/046664
Enrollment
120
Registered
2022-10-20
Start date
Unknown
Completion date
Unknown
Last updated
2022-11-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: Group B Adductor canal block with Ipack after spinal anesthesia: Ipack - 20 ml 0.25% bupivacaine and 1ml saline Adductor canal block - 10ml 0.25% bupivacaine and 1 ml saline Control

Sponsors

Suvina N
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients undergoing unilateral total knee arthroplasty

Exclusion criteria

Exclusion criteria: Patients who do not consent Emergency surgeries Patient with infection at planned site Patients planning to receive GA BMI >35 ASA > 3 Patients with coagulopathies Allergic to bupivacaine and magnesium Patients with coexisting kidney and cardiac disease

Design outcomes

Primary

MeasureTime frame
Vas scores at rest and movementTimepoint: 0,1,2,4,8,12,24 hours—

Secondary

MeasureTime frame
Time to rescue analgesia Adverse effectsTimepoint: 0,1,2,4,8,12,24 hours—

Countries

India

Contacts

Public ContactSuvina N

Vydehi Institute of Medical Sciences

suvi11492@gmail.com06366279888

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026